Hosted on MSN2d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...
GlobalData on MSN4d
Carilion to use BD’s needle-free blood draw device
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging ...
FierceBiotech3d
Masimo lands new CEO from BD's patient monitoring division
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...
3 in 4 women are skipping a routine appointment and putting themselves at higher risk for cancer
The survey of 1,100 women was conducted in November on behalf of global medical technology company Becton, Dickinson & ...
Pharmabiz2d
BD & Biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
BD To Announce Financial Results For Its First Quarter Of Fiscal 2025
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The ...
Is Becton, Dickinson and Company (BDX) an Undervalued Stock?
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy ...
BD Names Pamela Spikner as Chief Accounting Officer and Controller
FRANKLIN LAKES, N.J., Jan. 10, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela Spikner has been named ...
Global Gastric Cancer Diagnostics Market Is Anticipated To Grow At A CAGR Of ~7% By 2030, Estimates Delveinsight
Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...